• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在结肠腺癌中对[具体内容缺失]致癌作用及临床意义的鉴定。

Identification of the oncogenic role and clinical implication of in Colon Adenocarcinoma.

作者信息

Ye Kui, Cao Huaxiang, Xu Zihao, Liu Peng, Jiang Xueying, Liu Qiancheng, Yang Hongquan, Huo Menghua, Wang Teng, Wang Jian

机构信息

Department of Gastroenterology, Wuxi Second Geriatric Hospital, Wuxi Huishan Second People's Hospital, Wuxi, 214174, Jiangsu, China.

Department of Gastrointestinal Surgery, Affiliated Hospital of Jiangnan University, Wuxi, 214122, Jiangsu, China.

出版信息

J Cancer. 2025 Jan 1;16(1):81-91. doi: 10.7150/jca.102204. eCollection 2025.

DOI:10.7150/jca.102204
PMID:39744581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11660134/
Abstract

Colorectal carcinoma (CRC) is a highly prevalent and life-threatening disease with multi-stage progression, characterized by diverse molecular expression patterns at distinct stages, making treatment particularly challenging. Early detection and diagnosis of CRC are vital and can greatly benefit from the discovery of effective biomarkers. Researchers have identified novel gene signatures that play pivotal roles in specific CRC types or stages. Leucine Zipper Tumor Suppressor Family Member 3 (LZTS3), a well-known tumor suppressor in several cancer types such as lung carcinoma, has sparked interest. However, our comprehensive studies revealed a contrasting role for LZTS3 in CRC. We found that LZTS3 was highly expressed in CRC cases and associated with poor clinical outcomes. Gene enrichment analyses indicated that LZTS3 expression levels correlate with immune checkpoint inhibition, emphasizing the therapeutic potential of LZTS3 for colorectal adenocarcinoma (COAD). In conclusion, our results suggest a potential oncogenic role of LZTS3 in colorectal cancers, challenging previous perceptions of its function. Further research is needed to explore the precise mechanisms underlying this unexpected role and its implications for CRC diagnosis and therapy.

摘要

结直肠癌(CRC)是一种高度常见且危及生命的疾病,具有多阶段进展特征,在不同阶段表现出多样的分子表达模式,这使得治疗极具挑战性。CRC的早期检测和诊断至关重要,而发现有效的生物标志物能带来极大益处。研究人员已鉴定出在特定CRC类型或阶段起关键作用的新型基因特征。亮氨酸拉链肿瘤抑制因子家族成员3(LZTS3),在肺癌等多种癌症类型中是著名的肿瘤抑制因子,已引发关注。然而,我们的全面研究揭示了LZTS3在CRC中具有相反的作用。我们发现LZTS3在CRC病例中高表达,且与不良临床结果相关。基因富集分析表明,LZTS3表达水平与免疫检查点抑制相关,这凸显了LZTS3在结肠腺癌(COAD)中的治疗潜力。总之,我们的结果提示LZTS3在结直肠癌中具有潜在的致癌作用,挑战了以往对其功能的认知。需要进一步研究来探索这一意外作用背后的精确机制及其对CRC诊断和治疗的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/276c60598d59/jcav16p0081g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/7e1fa9207f91/jcav16p0081g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/796b937d71fe/jcav16p0081g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/cdc1123b4cd2/jcav16p0081g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/8b00d351736c/jcav16p0081g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/77acd3bcca38/jcav16p0081g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/861eb014dbf6/jcav16p0081g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/808ef13cf552/jcav16p0081g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/276c60598d59/jcav16p0081g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/7e1fa9207f91/jcav16p0081g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/796b937d71fe/jcav16p0081g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/cdc1123b4cd2/jcav16p0081g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/8b00d351736c/jcav16p0081g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/77acd3bcca38/jcav16p0081g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/861eb014dbf6/jcav16p0081g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/808ef13cf552/jcav16p0081g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b20/11660134/276c60598d59/jcav16p0081g008.jpg

相似文献

1
Identification of the oncogenic role and clinical implication of in Colon Adenocarcinoma.在结肠腺癌中对[具体内容缺失]致癌作用及临床意义的鉴定。
J Cancer. 2025 Jan 1;16(1):81-91. doi: 10.7150/jca.102204. eCollection 2025.
2
LZTS3/TAGLN Suppresses Cancer Progression in Human Colorectal Adenocarcinoma Through Regulating Cell Proliferation, Migration, and Actin Cytoskeleton.LZTS3/TAGLN 通过调控细胞增殖、迁移和肌动蛋白细胞骨架抑制人结直肠腺癌细胞的进展。
Arch Med Res. 2023 Nov;54(7):102894. doi: 10.1016/j.arcmed.2023.102894. Epub 2023 Oct 6.
3
LZTS3 represses tumorigenesis and radioresistance via CK1δ and β-TrCP-mediated ubiquitination pathway in lung cancer.LZTS3通过CK1δ和β-TrCP介导的泛素化途径抑制肺癌的肿瘤发生和放射抗性。
Cell Signal. 2025 May;129:111655. doi: 10.1016/j.cellsig.2025.111655. Epub 2025 Feb 14.
4
In silico characterization of LZTS3, a potential tumor suppressor.潜在肿瘤抑制因子LZTS3的计算机模拟特性分析
Oncol Rep. 2005 Aug;14(2):547-51.
5
LncRNA is correlated with prognosis and immune infiltration and facilitates tumor progression by targeting in colorectal cancer.长链非编码RNA(LncRNA)与结直肠癌的预后和免疫浸润相关,并通过靶向作用促进肿瘤进展。
Transl Cancer Res. 2024 Oct 31;13(10):5347-5364. doi: 10.21037/tcr-24-378. Epub 2024 Oct 18.
6
Identification and Validation of SLC9A2 as A Potential Tumor Suppressor in Colorectal Cancer: Integrating Bioinformatics Analysis with Experimental Confirmation.SLC9A2 作为结直肠癌潜在肿瘤抑制因子的鉴定和验证:生物信息学分析与实验验证的整合。
Curr Med Sci. 2024 Jun;44(3):529-544. doi: 10.1007/s11596-024-2871-5. Epub 2024 May 29.
7
Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.转录组学与结直肠腺癌中不同预后、分子特征、免疫调节和治疗反应相关的细胞周期检查点的相关性。
Front Immunol. 2023 Dec 8;14:1291859. doi: 10.3389/fimmu.2023.1291859. eCollection 2023.
8
Thalidomide attenuates radiation-induced apoptosis and pro-inflammatory cytokine secretion in oral epithelial cells by promoting LZTS3 expression.沙利度胺通过促进 LZTS3 表达来减轻口腔上皮细胞辐射诱导的细胞凋亡和促炎细胞因子分泌。
J Transl Med. 2024 Sep 27;22(1):863. doi: 10.1186/s12967-024-05648-z.
9
Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.研究与结肠腺癌免疫相关的基因特征,使用 NFM 和 WGCNA 算法预测免疫治疗效果。
Aging (Albany NY). 2024 May 13;16(9):7596-7621. doi: 10.18632/aging.205763.
10
The roles of lncRNA in clinical implications, immune landscape and carcinogenesis of colorectal cancer.长链非编码RNA在结直肠癌的临床意义、免疫格局及致癌过程中的作用。
Transl Cancer Res. 2024 Jul 31;13(7):3465-3481. doi: 10.21037/tcr-24-145. Epub 2024 Jul 19.

本文引用的文献

1
Survival rate of colorectal cancer in China: A systematic review and meta-analysis.中国结直肠癌的生存率:一项系统评价与荟萃分析。
Front Oncol. 2023 Mar 3;13:1033154. doi: 10.3389/fonc.2023.1033154. eCollection 2023.
2
Current Targeted Therapy for Metastatic Colorectal Cancer.转移性结直肠癌的当前靶向治疗。
Int J Mol Sci. 2023 Jan 15;24(2):1702. doi: 10.3390/ijms24021702.
3
Increasing burden of colorectal cancer in China.中国结直肠癌负担日益加重。
Lancet Gastroenterol Hepatol. 2022 Aug;7(8):700. doi: 10.1016/S2468-1253(22)00156-X.
4
Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家结直肠癌及其危险因素负担,1990-2019 年:2019 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2022 Jul;7(7):627-647. doi: 10.1016/S2468-1253(22)00044-9. Epub 2022 Apr 7.
5
Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better.肿瘤突变负担预测免疫检查点阻断反应:越多越好。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003087.
6
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis.CD8+肿瘤浸润淋巴细胞与癌症免疫治疗临床结局的关联:一项系统评价与荟萃分析。
EClinicalMedicine. 2021 Sep 16;41:101134. doi: 10.1016/j.eclinm.2021.101134. eCollection 2021 Nov.
7
Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients.基于 TNF 家族的signature 用于预测结直肠癌患者预后、肿瘤免疫特征和免疫治疗反应的开发和验证。
J Immunol Res. 2021 Sep 9;2021:6439975. doi: 10.1155/2021/6439975. eCollection 2021.
8
Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.加权基因共表达网络分析确定了一个与结肠腺癌患者的进展、预后和免疫微环境相关的新型13基因特征。
Front Genet. 2021 Jul 12;12:657658. doi: 10.3389/fgene.2021.657658. eCollection 2021.
9
Long non-coding RNA (lncRNA) PGM5P4-AS1 inhibits lung cancer progression by up-regulating leucine zipper tumor suppressor (LZTS3) through sponging microRNA miR-1275.长链非编码 RNA (lncRNA) PGM5P4-AS1 通过海绵吸附 microRNA miR-1275 上调亮氨酸拉链肿瘤抑制因子 (LZTS3) 抑制肺癌进展。
Bioengineered. 2021 Dec;12(1):196-207. doi: 10.1080/21655979.2020.1860492.
10
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s.通过诱导和激活肿瘤驻留的 cDC1 克服抗 PD-L1 治疗的原发性和获得性耐药性。
Nat Commun. 2020 Oct 27;11(1):5415. doi: 10.1038/s41467-020-19192-z.